Phosphatase and Tensin Homologue Deleted on Chromosome Ten (PTEN) As a Molecular Target in Lung Epithelial Wound Repair

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2007 Oct 9

PMID 17922022

Citations 32

Authors

J-P Lai

J T Dalton

D L Knoell

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Epithelial injury contributes to lung pathogenesis. Our work and that of others have identified the phosphoinositide-3 kinase (PI3K)/Akt pathway as a vital component of survival in lung epithelia. Therefore, we hypothesized that pharmacological inhibition of PTEN, a major suppressor of this pathway, would enhance wound closure and restore lung epithelial monolayer integrity following injury.

Experimental Approach: We evaluated the ability of two bisperoxovanadium derivatives, bpV(phen) and bpV(pic), in differentiated primary human airway epithelia and BEAS2B cultures for their ability to inhibit PTEN, activate the PI3K/Akt pathway and restore epithelial monolayer integrity following mechanical injury.

Key Results: BpV(phen) and bpV(pic) induced Akt phosphorylation in primary and BEAS2B cells in a dose and time dependent manner. Minimal toxicity was observed as measured by lactate dehydrogenase (LDH) release. To verify that Akt phosphorylation is specifically induced by PTEN inhibition, the PTEN positive cell line, DU145, and two PTEN negative cell lines, LNCaP and PC3, were examined. PTEN positive cells demonstrated a dose responsive increase in Akt phosphorylation whereas PTEN negative cells showed no response indicating that bpV(phen) directly suppresses PTEN without affecting auxiliary pathways. Next, we observed that exposure to either compound resulted in accelerated wound closure following mechanical injury. Similar effects were observed after transfection with a dominant negative isoform of PTEN and PTEN specific siRNA.

Conclusions And Implications: From these studies, we conclude that PTEN is a valid target for future studies directed at restoring epithelial barrier function after lung injury.

Citing Articles

D-tagatose protects against oleic acid-induced acute respiratory distress syndrome in rats by activating PTEN/PI3K/AKT pathway.

Huang J, Wang B, Tao S, Hu Y, Wang N, Zhang Q Front Immunol. 2022; 13:928312.

PMID: 36189316 PMC: 9520915. DOI: 10.3389/fimmu.2022.928312.

PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Cai B, Yang L, Do Jung Y, Zhang Y, Liu X, Zhao P Oxid Med Cell Longev. 2022; 2022:4512503.

PMID: 35814272 PMC: 9262564. DOI: 10.1155/2022/4512503.

Pharmacological inhibition of the lipid phosphatase PTEN ameliorates heart damage and adipose tissue inflammation in stressed rats with metabolic syndrome.

Ashikawa S, Komatsu Y, Kawai Y, Aoyama K, Nakano S, Cui X Physiol Rep. 2022; 10(1):e15165.

PMID: 35005845 PMC: 8744130. DOI: 10.14814/phy2.15165.

MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies.

Li Y, Fan C, Wang L, Lan T, Gao R, Wang W J Clin Invest. 2021; 131(16).

PMID: 34228643 PMC: 8363293. DOI: 10.1172/JCI148853.

Pharmacological PTEN inhibition: potential clinical applications and effects in tissue regeneration.

Borges G, Webber L, Marques A, Guerra E, Castilho R, Squarize C Regen Med. 2020; 15(2):1329-1344.

PMID: 32223643 PMC: 7202261. DOI: 10.2217/rme-2019-0065.

References

Tamura M, Gu J, Takino T, Yamada K . Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 1999; 59(2):442-9. View

Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B . Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. 1997; 272(2):843-51. DOI: 10.1074/jbc.272.2.843. View

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

Bao S, Wang Y, Sweeney P, Chaudhuri A, Doseff A, Marsh C . Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004; 288(1):L36-42. DOI: 10.1152/ajplung.00309.2003. View

Cerovac Z, Ban J, Morinville A, Yaccato K, Shaver A, Maysinger D . Activation of MAPK by potassium bisperoxo(1,10-phenanthroline)oxovanadate (V). Neurochem Int. 1999; 34(4):337-44. DOI: 10.1016/s0197-0186(99)00018-2. View

Jain L, Eaton D . Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006; 30(1):34-43. DOI: 10.1053/j.semperi.2006.01.006. View

Weng L, Brown J, Eng C . PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet. 2001; 10(6):599-604. DOI: 10.1093/hmg/10.6.599. View

Gordon J . Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 1991; 201:477-82. DOI: 10.1016/0076-6879(91)01043-2. View

Lee J, Yang H, Georgescu M, Di Cristofano A, Maehama T, Shi Y . Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell. 1999; 99(3):323-34. DOI: 10.1016/s0092-8674(00)81663-3. View

10.

Ray P, Devaux Y, Stolz D, Yarlagadda M, Watkins S, Lu Y . Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci U S A. 2003; 100(10):6098-103. PMC: 156332. DOI: 10.1073/pnas.1031851100. View

11.

Datta P, Lianos E . Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int. 1999; 56(2):486-93. DOI: 10.1046/j.1523-1755.1999.00576.x. View

12.

Schmid A, Byrne R, Vilar R, Woscholski R . Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett. 2004; 566(1-3):35-8. DOI: 10.1016/j.febslet.2004.03.102. View

13.

Wu X, Hepner K, Do D, Kaye M, Yuan X, Wood J . Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A. 2000; 97(8):4233-8. PMC: 18208. DOI: 10.1073/pnas.97.8.4233. View

14.

Butler M, McKay R, Popoff I, Gaarde W, Witchell D, Murray S . Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes. 2002; 51(4):1028-34. DOI: 10.2337/diabetes.51.4.1028. View

15.

Vinciguerra M, Foti M . PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling. Arch Physiol Biochem. 2006; 112(2):89-104. DOI: 10.1080/13813450600711359. View

16.

Stambolic V, Suzuki A, de la Pompa J, Brothers G, Mirtsos C, Sasaki T . Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95(1):29-39. DOI: 10.1016/s0092-8674(00)81780-8. View

17.

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

18.

Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

19.

Ray P . Protection of epithelial cells by keratinocyte growth factor signaling. Proc Am Thorac Soc. 2005; 2(3):221-5. PMC: 2713320. DOI: 10.1513/pats.200502-012AC. View

20.

Rumora L, Hadzija M, Maysinger D, Zanic-Grubisic T . Positive regulation of ERK activation and MKP-1 expression by peroxovanadium complex bpV (phen). Cell Biol Toxicol. 2005; 20(5):293-301. DOI: 10.1007/s10565-004-5104-5. View